← All companies

NAGE

Niagen Bioscience, Inc.

NAGE Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗

$3.53

+0.13 +3.82%

Key statistics

from XBRL data in SEC filings

Market cap

$281M

Revenue (TTM)

$130M

Net income (TTM)

$18.6M

EPS (TTM)

$0.21

P/E ratio

16.8

Dividend yield

—

Free cash flow

$12.8M

Cash

$66.5M

Total assets

$114M

Gross margin

64.3%

52-week range

$3.12 – $11.29

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Other events Mar 19, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Regulation FD disclosure; Other events Feb 26, 2026 8-K Entered a material agreement; Regulation FD disclosure Dec 22, 2025 8-K Other events Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Regulation FD disclosure Oct 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Entered a material agreement Jul 29, 2025 8-K Director or officer change; Shareholder vote results Jun 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Amended charter or bylaws; Regulation FD disclosure Mar 19, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Director or officer change Feb 27, 2025 8-K Changed accountants Dec 16, 2024 8-K Other events Dec 4, 2024 8-K Entered a material agreement Nov 21, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 31, 2024 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Changed accountants Oct 11, 2024 8-K Director or officer change Sep 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Director or officer change Jul 16, 2024 8-K Director or officer change Jun 25, 2024 8-K Shareholder vote results Jun 24, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 6, 2024 10-K Fiscal year ended 2023-12-31 Mar 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 13, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2023